CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-02 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −11,008 | $23.56 | $259K | 13,579 |
| 2026-07-02 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,221 | 0 | ||
| 2026-07-02 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,787 | 128,611 | ||
| 2026-06-25 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +13,333 | $7.26 | $97K | 26,912 |
| 2026-06-25 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +15,602 | $8.72 | $136K | 42,514 |
| 2026-06-25 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −28,935 | $20.06 | $581K | 13,579 |
| 2026-06-25 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −13,333 | 0 | ||
| 2026-06-25 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,602 | 134,398 | ||
| 2026-06-25 | Hansen Gwenn Chief Scientific Officer | Sale 10b5-1 | −5,394 | $20.00 | $108K | 115,005 |
| 2026-06-02 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +3,422 | $1.86 | $6K | 21,727 |
| 2026-06-02 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −8,148 | $16.60 | $135K | 13,579 |
| 2026-06-02 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,422 | 5,221 | ||
| 2026-05-15 | Saltzman Edward C Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | DANSEY ROGER D Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | Lacey David L. Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | Kapur Anil Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | Baynes Roy D. Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | Silva Paul M Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | Reinsdorf Judith A Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2026-05-15 | GREGORY JULIA P Director | Grant or award · Director Stock Option (right to buy) | +31,250 | 31,250 |
Page 5 of 20 · 381 trades